These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25489300)

  • 61. Percutaneous patent foramen ovale closure: the Paradoxical Cerebral Embolism Prevention Registry.
    Paiva L; Dinis P; Providência R; Costa M; Margalho S; Goncalves L
    Rev Port Cardiol; 2015 Mar; 34(3):151-7. PubMed ID: 25727752
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patent foramen ovale--assessment and treatment.
    Irwin B; Ray S
    Cardiovasc Ther; 2012 Jun; 30(3):e128-35. PubMed ID: 21883994
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of Discontinuation of Antithrombotic Therapy Following Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
    Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Guimaraes LFC; Côté M; Rodés-Cabau J
    Am J Cardiol; 2019 May; 123(9):1538-1545. PubMed ID: 30792001
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
    JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.
    Ford MA; Reeder GS; Lennon RJ; Brown RD; Petty GW; Cabalka AK; Cetta F; Hagler DJ
    JACC Cardiovasc Interv; 2009 May; 2(5):404-11. PubMed ID: 19463462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia.
    Braun MU; Fassbender D; Schoen SP; Haass M; Schraeder R; Scholtz W; Strasser RH
    J Am Coll Cardiol; 2002 Jun; 39(12):2019-25. PubMed ID: 12084603
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
    Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G
    Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcatheter closure of patent foramen ovale for secondary prevention of ischemic stroke: Quantitative synthesis of pooled randomized trial data.
    Hakeem A; Cilingiroglu M; Katramados A; Boudoulas KD; Iliescu C; Gundogdu B; Marmagkiolis K
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1153-1160. PubMed ID: 29332308
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcome of patients with cryptogenic stroke and patent foramen ovale.
    Nedeltchev K; Arnold M; Wahl A; Sturzenegger M; Vella EE; Windecker S; Meier B; Mattle HP
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):347-50. PubMed ID: 11861693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Secondary prevention of cryptogenic stroke in patients with patent foramen ovale: a systematic review and meta-analysis.
    Fiorelli EM; Carandini T; Gagliardi D; Bozzano V; Bonzi M; Tobaldini E; Comi GP; Scarpini EA; Montano N; Solbiati M
    Intern Emerg Med; 2018 Dec; 13(8):1287-1303. PubMed ID: 30032341
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Five-year experience with percutaneous closure of patent foramen ovale.
    Slavin L; Tobis JM; Rangarajan K; Dao C; Krivokapich J; Liebeskind DS
    Am J Cardiol; 2007 May; 99(9):1316-20. PubMed ID: 17478165
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
    Fortuni F; Crimi G; Leonardi S; Angelini F; Raisaro A; Lanzarini LF; Oltrona Visconti L; Ferrario M; De Ferrari GM
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):373-381. PubMed ID: 29708911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Explantation of patent foramen ovale closure devices: a multicenter survey.
    Verma SK; Tobis JM
    JACC Cardiovasc Interv; 2011 May; 4(5):579-85. PubMed ID: 21596333
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.
    Agarwal S; Bajaj NS; Kumbhani DJ; Tuzcu EM; Kapadia SR
    JACC Cardiovasc Interv; 2012 Jul; 5(7):777-89. PubMed ID: 22814784
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patent foramen ovale closure in patients with transient ischemia attack/stroke.
    Sievert H; Horvath K; Zadan E; Krumsdorf U; Fach A; Merle H; Scherer D; Schräder R; Spies H; Nowak B; Lissmann-Jensen H
    J Interv Cardiol; 2001 Apr; 14(2):261-6. PubMed ID: 12053315
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses.
    Udell JA; Opotowsky AR; Khairy P; Silversides CK; Gladstone DJ; O'Gara PT; Landzberg MJ
    Can J Cardiol; 2014 Oct; 30(10):1216-24. PubMed ID: 25154803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.